[ Price : $8.95]
Federal Register Notice: FDAs Circulatory System Devices Panel will meet 12/7-8 to discuss stent thrombosis in coronary drug-eluti...[ Price : $8.95]
FDA generic drugs counsel David Read says citizens petitions which critics charge are often used by branded drug manufacturers to...[ Price : $8.95]
As resistance to user fees grows, FDA gets $100,000 to study the feasibility of extending user fees to the review of generic drugs...[ Price : $8.95]
DDMAC wants corrective messages for misleading Mallinckrodt MD-Gastroview, Optimark booth panels.[ Price : $8.95]
Federal Register Notice: FDA releases a guidance document on biological product deviation reporting for blood and plasma establish...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance on biological product deviation reporting for licensed manufacturers of biologica...[ Price : $8.95]
An FDA panel votes to recommend a label revision for breast cancer drug tamoxifen to reflect clinical evidence showing that women ...[ Price : $8.95]
FDA clears a InfraReDx 510(k) application to market a near-infrared spectroscopic system for examining coronary arteries.